Seoul, South Korea

Jeesoo Son


 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Jeesoo Son: Innovator in Bacteriophage Technology**

Introduction

Jeesoo Son, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology. With a total of 8 patents to his name, Son has focused on innovative solutions for treating infections caused by bacterial biofilms, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Among his latest innovations, Jeesoo Son has developed a groundbreaking composition that features the bacteriophage EK99P-1. This natural bacteriophage is particularly effective in targeting and eradicating type K99 bacteria, making it a pivotal component for preventing and treating infections associated with this strain. Additionally, Son's recent patent addresses the removal of biofilms formed by various bacterial strains. This invention utilizes specific phage and lytic proteins to disrupt biofilms, thereby providing a method to counteract diseases linked to biofilm formation.

Career Highlights

Currently, Jeesoo Son is a member of Intron Biotechnology, Inc., where he continues to push the boundaries of bacteriophage research and applications. His work is characterized by a strong commitment to improving therapeutic options for bacterial infections, particularly those resistant to conventional treatment methods.

Collaborations

Collaboration plays a crucial role in Son's innovative journey. He has worked alongside notable colleagues such as Seongjun Yoon and Sanghyeon Kang, contributing to a rich environment of shared ideas and collaborative advancements in research. Together, they continue to explore the vast potential of bacteriophage technology.

Conclusion

Jeesoo Son stands out as a prominent inventor in the biotechnology sector, with his work on bacteriophage applications paving the way for future innovations in infection treatment. With a solid portfolio of patents, Son is dedicated to advancing healthcare solutions, making him a significant figure in the ongoing battle against bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…